grant

Targeting anoctamin 6 to disrupt trogocytosis of cancer-associated fibroblasts

Organization RESEARCH INST OF FOX CHASE CAN CTRLocation PHILADELPHIA, UNITED STATESPosted 7 Mar 2025Deadline 28 Feb 2030
NIHUS FederalResearch GrantFY2026Blood PlasmaBlood VesselsCalciumCalcium Ion SignalingCalcium SignalingCancer BiologyCancersCell BodyCell Communication and SignalingCell Membrane LipidsCell ProtectionCell SignalingCell SurvivalCell ViabilityCell membraneCell-Mediated Lympholytic CellsCellsCholesterolCytolytic T-CellCytoplasmic MembraneCytoprotectionCytosolCytotoxic T CellCytotoxic T-LymphocytesEatingFibroblastsFood IntakeGatekeepingGeneralized GrowthGreekGrowthHumanImmuneImmune mediated therapyImmunesImmunityImmunologically Directed TherapyImmunosuppressionImmunosuppression EffectImmunosuppressive EffectImmunotherapyIntercellular FluidInterstitial FluidsIntracellular Communication and SignalingKnowledgeLabelLipidsMalignant CellMalignant NeoplasmsMalignant TumorMembraneMembrane LipidsMiceMice MammalsMicroscopyModern ManMolecularMurineMusNutrientOutcomePDAC cancer cellPDAC cellPancreas AdenocarcinomaPancreas Ductal AdenocarcinomaPancreas NeoplasmsPancreas TumorPancreatic AdenocarcinomaPancreatic Ductal AdenocarcinomaPancreatic TumorPathway interactionsPatientsPhosphatidylserinesPlasmaPlasma MembranePlasma SerumPositionPositioning AttributeProcessProteinsResistanceReticuloendothelial System, Serum, PlasmaRoleSTIM1STIM1 geneSerine PhosphoglyceridesSignal TransductionSignal Transduction SystemsSignalingStromal Interaction Molecule 1StructureSynapsesSynapticT-CellsT-LymphocyteTestingTherapeuticTherapeutic InterventionTissue GrowthTumor CellTumor Immunityanti-canceranti-cancer immunotherapyanti-tumor immunityanticancer immunotherapyantitumor immunitybiological signal transductioncancer cellcancer immunitycancer immunotherapycancer microenvironmentcytoprotectivedensityexhaustionexperimentexperimental researchexperimental studyexperimentsfat metabolismfeedinggatekeeperimmune suppressionimmune suppressive activityimmune suppressive functionimmune therapeutic approachimmune therapeutic interventionsimmune therapeutic regimensimmune therapeutic strategyimmune therapyimmune-based cancer therapiesimmune-based therapiesimmune-based treatmentsimmuno therapyimmunogenicityimmunosuppressive activityimmunosuppressive functionimmunosuppressive responseimmunotherapy for cancerimmunotherapy of cancerinhibitorintervention therapykiller T celllipid metabolismmalignancymembrane structureneoplasm/cancerneoplastic cellnew drug targetnew drug treatmentsnew druggable targetnew drugsnew pharmacological therapeuticnew pharmacotherapy targetnew therapeutic targetnew therapeuticsnew therapynew therapy targetnext generation therapeuticsnonspecific phospholipid transfer proteinsnovelnovel drug targetnovel drug treatmentsnovel druggable targetnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel pharmacotherapy targetnovel therapeutic targetnovel therapeuticsnovel therapynovel therapy targetontogenypancreatic cancer cellspancreatic ductal adenocarcinoma cellpancreatic neoplasiapancreatic neoplasmpancreatic tumor cellsparticlepathwayphospholipid scramblaseplasmalemmapreventpreventingresistantresponsesocial rolesynapsethymus derived lymphocytetumortumor microenvironmentuptakevascular
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Project Summary
The fibroblastic stroma comprises most of pancreatic adenocarcinoma mass and is remarkably devoid of

functional blood vessels. It has been assumed that the pancreatic cancer cells obtain their essential metabolites,

such as lipids, directly from the interstitial fluid, but we have found that this is not the case. Instead, we…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Targeting anoctamin 6 to disrupt trogocytosis of cancer-associated fibroblasts — RESEARCH INST OF FOX CHASE CAN CTR | UN | Dev Procure